ICDcodes.org
FY2027

E74.819Disorders of glucose transport, unspecified

BillableUnspecifiedCC

Is E74.819 billable?

Yes, but E74.819 is an unspecified code. E74.819 is a valid, billable ICD-10-CM code for encounters from October 1, 2026 through September 30, 2027. However, E74.819 is an unspecified or catch-all code. Payers apply additional scrutiny to unspecified codes and many deny them when the medical record supports a more specific option, so check the documentation before selecting E74.819 — the more specific alternatives are listed below.

E74.819 at a glance

CodeE74.819
DescriptionDisorders of glucose transport, unspecified
BillableYes
Code setICD-10-CM FY2027
Valid for encountersOctober 1, 2026 – September 30, 2027

Which MS-DRGs does E74.819 group to?

E74.819 sits in MDC 10 and helps define the logic of 1 MS-DRG (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.

  • 642Inborn and Other Disorders of Metabolismmedical

As a secondary diagnosis, E74.819 is a complication or comorbidity (CC), which can move a stay into a higher-paying DRG.

How is E74.819 listed in the Alphabetic Index?

These are the routes through the Alphabetic Index that lead to E74.819. They show the wording a clinician may have documented, which often differs from the Tabular description.

  • Disorderglucose transport (of)

Excludes1 — never code together — inherited from Chapter 4

The conditions below can never be reported together with E74.819 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • transitory endocrine and metabolic disorders specific to newborn (P70-P74)

Excludes1 — never code together — inherited from E70-E88

The conditions below can never be reported together with E74.819 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • androgen insensitivity syndrome (E34.5-)
  • congenital adrenal hyperplasia (E25.0)
  • hemolytic anemias attributable to enzyme disorders (D55.-)
  • Marfan syndrome (Q87.4-)
  • 5-alpha-reductase deficiency (E29.1)

Excludes1 — never code together — inherited from E74

The conditions below can never be reported together with E74.819 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • diabetes mellitus (E08-E13)
  • hypoglycemia NOS (E16.2)
  • increased secretion of glucagon (E16.3)
  • mucopolysaccharidosis (E76.0-E76.3)

Excludes2 — not included here — inherited from E70-E88

The conditions below are not part of E74.819, but a patient may have both at the same time. When documentation supports it, E74.819 and the excluded code may both be reported.

  • Ehlers-Danlos syndromes (Q79.6-)

How long has E74.819 existed?

E74.819 first appears in FY2021 (FY2020 is not available, so it may have appeared then).

Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.

What other codes are in the E74.81 family? (2)